FTSE 100 today: Index edges higher; Centrica gains on Sizewell C stake
Investing.com -- Oscar Health has increased its full-year revenue forecast to between $12 billion and $12.2 billion, up from its previous guidance of $11.20 billion to $11.30 billion. This new outlook exceeds the average analyst estimate of $11.32 billion.
Despite the improved revenue projection, Oscar Health shares fell 1.7% in premarket trading Tuesday.
The health insurance company reported a preliminary net loss of approximately $228 million for the second quarter of 2025. The updated guidance follows a review of 2025 Marketplace data, specifically the "2Q Risk Adjustment Reports" from Wakely.
Oscar Health now projects a medical loss ratio of 86.0% to 87.0% for the full year 2025. While utilization by Oscar’s members remained elevated in the second quarter, cost trends showed moderation compared to the first quarter of 2025.
The company plans to resubmit rate filings for 2026 in states covering approximately 98% of its current membership. These resubmissions will reflect the higher market risk scores in the Affordable Care Act Marketplace.
For the year, Oscar Health expects an Adjusted EBITDA loss of approximately $120 million less than its Loss from Operations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.